| Karen Lemons, | |
|
900 Virginia St E, Charleston, WV 25301-2835 | |
| (618) 313-4759 | |
| Not Available |
| Full Name | Karen Lemons |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Home Health |
| Location | 900 Virginia St E, Charleston, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104535053 | NPI | - | NPPES |
| 84664 | Other | WV | WV NURSING LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WH0200X | Registered Nurse - Home Health | 84664 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen Lemons, 900 Virginia St E, Charleston, WV 25301-2835 Ph: (618) 313-4759 | Karen Lemons, 900 Virginia St E, Charleston, WV 25301-2835 Ph: (618) 313-4759 |
News Archive
Researchers from Germany and the US investigated the efficacy of neutralizing antibodies against newer variants using serum and saliva samples obtained from groups of infected, vaccinated (with Pfizer BNT-162b2), and uninfected individuals. The researchers started this study to uncover vaccine-induced immune response and show the efficiency of antibody binding and neutralization in SARS-CoV-2 variants.
Health Fitness Corporation, a leading provider of integrated employee health and productivity management solutions, today announced that MillerCoors recently awarded HealthFitness an expanded role in leading its company-wide health management strategy.
Ever get a little motion sick from an illusion graphic designed to look like it's moving?
The National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, is awarding a total of $6.8 million for the first year of funding to three new research centers called DISCOVER - Disease Investigation Through Specialized Clinically-Oriented Ventures in Environmental Research.
Abraxis BioScience, Inc. announced today that findings from a phase 1 randomized trial demonstrated that the nanoparticle albumin bound (nab®) driven chemotherapy, nab-paclitaxel (ABRAXANE® for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension) is well-tolerated and active in the second-line treatment of high-grade, non-muscle-invasive bladder cancer that has been refractory to standard intra-bladder infusion (intravesical) therapy.
› Verified 4 days ago
April Griffith, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth Street, Charleston, WV 25311 Phone: 304-348-7740 | |
Amanda Jordan, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7770 | |
Carrie Lynn Weber, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 400 Tracy Way, Charleston, WV 25311 Phone: 304-720-0205 | |
Cindy Miller, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 900 Virginia St E Ste 400, Charleston, WV 25301 Phone: 681-313-4759 | |
Teresa Gayle Waugh, RN, CDE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3110 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-388-5555 Fax: 304-355-5560 | |
Linda Powers, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 | |
Emily Moore, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-766-7655 |